ArticleCureus2026
Preoperative Albumin-Bilirubin Score as a Predictor of Postoperative Complications After Liver Resection.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionHepatic resection is an important curative procedure for both benign and malignant liver diseases, and the risks associated with liver resection, especially posthepatectomy liver failure (PHLF), are still a major concern. This is the reason why it is clear that the correct evaluation of hepatic functional reserve is imperative before surgery. The conventional scoring systems, like Model for End-stage Liver Disease (MELD) and Child-Turcotte-Pugh (CTP), are less effective in predicting postoperative morbidity. An objective, inexpensive method, the albumin-bilirubin (ALBI) score, involving serum albumin and bilirubin, can be helpful in a resource-limited setting.
objectiveThe objective of this study was to determine the preoperative ALBI score for predicting postoperative complications of patients undergoing hepatic resection. MATERIALS AND
methodsThis is a prospective observational study carried out in the Department of Hepatobiliary, Pancreatic and Liver Transplant Surgery (HBLT) of Bangabandhu Sheikh Mujib Medical University (now Bangladesh Medical University (BMU)), Dhaka, from August 2023 till July 2024. The number of adult patients who underwent liver resection and met the inclusion criteria was 70, who were sampled purposively. All of the demographic, laboratory, clinical, and operative data were documented preoperatively. Presurgery scores for ALBI, CTP, and MELD were calculated. The postoperative complications were assessed within 30 days. Data were analyzed with Statistical Package for the Social Sciences (SPSS) version 23, and receiver operating characteristic curve (ROC) analysis was used to assess the predictive accuracy of ALBI.
resultsOut of 70 patients, 30 patients (42.9%) had postoperative complications. Patients with postoperative complications were significantly older than those without complications (50.67 ± 7.06 vs. 44.68 ± 10.26 years;
conclusionPreoperative ALBI score was significantly associated with postoperative complications and showed weak-to-moderate discriminatory ability. ALBI as having weak-to-moderate discriminatory ability and as a possible adjunctive marker, not a strong predictive test or replacement for clinical judgment and established scoring systems, but larger multicenter studies are needed to validate its cut-off and clinical usefulness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.